Clinical trials
Pediatric ALL clinical trials
Below are recruiting pediatric all clinical trials, each written for real people, not researchers. We’re tracking 1,376 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06286098Enrolling by invitationPhase 3
Alpha lipoic acid for kids on dialysis
This trial tests if alpha lipoic acid, a common supplement, can help reduce stress on the body for children who are on regular hemodialysis. It may offer a way to support their health during treatment.
Cairo, El WeiliAges 8–16 - NCT05740839Recruiting
High-intensity exercise program for young brain tumor survivors
This pilot study tests whether a high-intensity interval exercise routine is safe and doable for young adult survivors of pediatric brain tumors. It may help you improve fitness and quality of life while researchers closely monitor safety.
Boston, MassachusettsAges 18–45 - NCT05902234Recruiting
Using body maps to study children’s pain emotions
This study looks at how children with pain and their parents describe emotions connected to where it hurts using “body maps.” It may help researchers better understand emotional and pain experiences in families.
HelsinkiAges 10–80 - NCT05455918RecruitingPhase 2
Chemo with paclitaxel, ifosfamide, and cisplatin for high-risk germ cell tumors
This Phase 2 trial tests a specific chemotherapy combination (paclitaxel, ifosfamide, and cisplatin) for children and teens with newly diagnosed, high-risk germ cell tumors. It aims to improve outcomes by treating cancer cells with a stronger chemo plan.
SeoulAges 1–20 - NCT05608148RecruitingPhase 1
GAIA-102 for relapsed or hard-to-treat childhood cancers
This Phase 1 study tests GAIA-102 in children and young adults whose cancer has returned or not responded to standard treatments. It aims to see if the treatment is safe and whether it may shrink tumors in certain pediatric solid cancers.
Fukuoka, FukuokaAges 1–24 - NCT05068583Recruiting
Testing liquid blood samples in children with certain cancers
This trial studies “liquid biopsies,” which are blood tests, to help learn about specific cancers in children. It may help doctors monitor cancer and guide treatment using less invasive tests.
Los Angeles, CaliforniaAges 6 months+ - NCT04929236RecruitingPhase 3
Testing different PANZYGA doses for children with CIDP
This Phase 3 study compares different dose schedules of PANZYGA (immune-globulin) in children with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). It aims to find a dosing plan that is both safe and effective for improving symptoms and function.
Birmingham, AlabamaAges 2–17 - NCT05267821RecruitingPhase 2/Phase 3
Testing anakinra to reduce inflammation in pediatric sepsis MODS
This study tests whether a medicine called anakinra can “turn down” harmful inflammation in children with severe illness from sepsis. It aims to improve organ function when multiple organs are starting to fail.
Birmingham, AlabamaAges 1 day–17 years - NCT04669457Enrolling by invitationPhase 4
Study of delirium risk in young children having ear surgery
This trial looks at confusion or “delirium” after anesthesia in babies and young children having a myringotomy (ear procedure). It may help doctors understand which children are more likely to experience delirium and how to reduce that risk.
Worcester, MassachusettsAges 3 months–9 years - NCT04253379Recruiting
Study of social understanding in children with epilepsy
This study looks at how children with epilepsy understand social cues, compared with other children the same age. You may be asked to complete simple thinking and social tasks to see what differences exist and what they might mean.
ReimsAges 6–12 - NCT02539407Recruiting
Study drug levels in critically ill children
This trial measures how anti-infective medicines move through a child’s body while they are in the hospital or during follow-up. The goal is to better understand dosing and drug exposure in critically ill children.
ParisAges 1 day–18 years - NCT03684018RecruitingPhase 4
Testing two doses of Privigen for children with CIDP
This study tests whether two different dose levels of Privigen (a type of immune blood treatment) are safe and effective for children and teens with CIDP. It may help improve nerve-related symptoms in people whose CIDP has been confirmed or is being evaluated as likely.
Phoenix, ArizonaAges 2–17 - NCT03063216Recruiting
Study of treatment outcomes for children with cataracts
This study looks at children who have cataracts (clouding of the eye lens) and how well treatments and eye care go. You may be able to take part if your child can cooperate with eye exams and does not have certain mental or learning conditions that affect participation.
Shanghai, Shanghai MunicipalityAges 2 months–20 years - NCT06369584Recruiting
Prone Position for Children on ECMO with Severe ARDS
This trial tests if lying face-down (prone position) helps children with severe ARDS who are already on ECMO, a machine that supports the heart and lungs. It aims to see if this position improves recovery.
Beijing, Beijing MunicipalityAges 1 month–18 years - NCT03500133RecruitingPhase 4
Low-dose chemotherapy and less radiation for childhood Hodgkin lymphoma
This trial studies a treatment plan for children with classical Hodgkin lymphoma that uses lower total doses of chemotherapy and reduced radiation. The goal is to help control the lymphoma while lowering long-term side effects.
Buenos Aires, Buenos Aires F.D.Ages 2–18 - NCT06262438RecruitingPhase 2
Quizartinib plus chemo for children with FLT3-ITD AML
This study adds a targeted drug called quizartinib to standard chemotherapy for children with a certain type of acute myeloid leukemia (AML) that has a FLT3-ITD gene change. The goal is to see if this combination is safe and effective for treating newly diagnosed patients.
Utrecht, UtrechtAges 1 month–18 years - NCT03761121Recruiting
Imaging study for low-grade glioma in children and adults
This study is testing how to take faster, better brain images in people diagnosed with low-grade glioma (a type of brain tumor). Better imaging may help doctors see the tumor more clearly while reducing time spent in the scanner.
Boston, MassachusettsAges birth+ - NCT01696721Recruiting
Pediatric radiation therapy registry for children under 22
This study is a registry that collects information from children and teens who receive radiation therapy at participating hospitals. It helps researchers learn how radiation is used in pediatrics and may improve future care.
Palo Alto, CaliforniaAges Up to 21 years - NCT07267364Recruiting
Pelvic floor exercises for children with bladder issues
This study tests two types of exercises to help children with bladder control problems. It compares standard pelvic floor training with a special exercise approach that may improve how the bladder and muscles work together.
Konya, KonyaAges 5–18 - NCT07515937Recruiting
3D-Printed Bite Splint for Broken Jaws in Children
This study tests a custom 3D-printed bite splint to help heal straightforward jaw fractures in children aged 6–12. Instead of surgery, the splint guides the broken pieces back together while your child heals naturally.
Cairo, Cairo GovernorateAges 6–12 - NCT07241286Enrolling by invitation
Enhanced Recovery Program for Kids After Lung Surgery
This trial tests a program to help children recover faster after lung surgery. The program focuses on improving recovery and reducing hospital stays.
Taipei, TaiwanAges birth–18 years - NCT07694934Recruiting
VR mindfulness for anxiety before pediatric surgery
This trial tests whether a virtual reality mindfulness program can help reduce anxiety in children and teens before surgery. If you are scheduled for surgery, you may be able to use a VR headset to practice calming exercises.
MontrealAges 10–17 - NCT06397027RecruitingPhase 1
Ziftomenib, venetoclax, and azacitidine for pediatric leukemia
This trial tests a new drug combination (ziftomenib, venetoclax, and azacitidine) in children and young adults with acute leukemia that has come back or not responded to treatment. It may help if your child's leukemia has certain genetic changes (like KMT2A, NPM1, or NUP98).
Houston, TexasAges 2–21 - NCT06760117RecruitingPhase 1
Gene-guided chemo for kids with relapsed solid tumors
This trial tests a new combination of chemotherapy drugs (irinotecan, temozolomide, and vincristine) for children whose solid tumors have come back or not responded to standard treatment. It aims to see if a specific gene test can help doctors choose the right dose of irinotecan to reduce side effects.
Guangzhou, GuangdongAges Up to 18 years
Hear when a new Pediatric ALL trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pediatric all?
- Yes. Clin2 currently lists 1,376 recruiting pediatric all studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pediatric all trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pediatric all trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Beyond the search
We also like to point to nonprofits doing real good in this area. We aren’t affiliated with them — we just admire the work.
- Children’s Oncology Support FundChildren with cancer and the families caring for them.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.